KORU Medical Systems vs Retractable Technologies
KRMD and RVP side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KRMD and RVP compare
KORU Medical Systems is the larger company, worth 9.5 times as much as Retractable Technologies ($161M against $16.9M).
KORU Medical Systems grew revenue faster over the last twelve months (22.4% versus −11.2% for Retractable Technologies).
KORU Medical Systems keeps more of each dollar of sales as profit, with a net margin of −4.0% compared with −9.9% at Retractable Technologies.
KORU Medical Systems scores higher on the StockData Score (12 against 11 for Retractable Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KRMD | RVP |
|---|---|---|
| Size and price | ||
| Market cap | $161M | $16.9M |
| Share price | $3.49 | $0.565 |
| Change, 1 year | −19.2% | −27.4% |
| Change, 5 years | −4.4% | −93.5% |
| Beta (5Y) | 1.09 | 0.39 |
| Employees | 73 | 201 |
| StockData Score | ||
| Total score | 12 (better) | 11 |
| Valuation score | 0 | 3 (better) |
| Growth score | 3 (better) | 1 |
| Performance score | 3 | 3 |
| Health score | 6 (better) | 4 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 3.6× | 0.5× (better) |
| P/B | 8.9× | 0.2× (better) |
| P/FCF | 207× | – |
| FCF yield | 0.48% | – |
| Fair value | $2.67 | $3.11 |
| Margin of safety | −30.9% | 81.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 22.4% (better) | −11.2% |
| Revenue growth, 5Y average | 11.2% (better) | −14.1% |
| Profitability | ||
| Gross margin | 62.4% (better) | −1.4% |
| Operating margin | −3.7% (better) | −66.9% |
| Net margin | −4.0% (better) | −9.9% |
| FCF margin | 1.7% | – |
| Return on equity | −10.5% | −4.5% (better) |
| Return on invested capital | −14.3% (better) | −24.8% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | – | −278.8× |
| Current ratio | 2.72 | 4.93 (better) |
| Altman Z-score | 10.07 (better) | 0.43 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 44.5% | 8.8% |
| Held by insiders | 17.6% | 55.7% |
| Insider net buying, 12 months | $1.6M (better) | $0 |
| Short interest, % of float | 2.3% | 0.17% |
Go deeper
- KRMD stock overview
- KRMD income statement
- KRMD valuation and score
- RVP stock overview
- RVP income statement
- RVP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.